Breast Imaging Market Updates

Breast Imaging Market size was valued at USD 4.4 Billion in 2023 and is poised to grow from USD 4.77 Billion in 2024 to USD 9.17 Billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

Developing affordable and advanced breast imaging solutions that are accessible to all women should be the prime focus of breast imaging providers in the future. Use of advanced imaging technologies and integration of advanced technologies could also help improve diagnosis for breast imaging companies going forward. Breast imaging providers can also unify multiple imaging technologies to create a all-inclusive solution that has the benefits of all imaging technologies. 'GE Healthcare (US) ', 'Hologic, Inc. (US) ', 'Siemens Healthcare GmbH (Germany) ', 'Koninklijke Philips N.V. (Netherlands) ', 'FUJIFILM Holdings Corporation (Japan) ', 'Canon Inc. (Japan) ', 'Aurora Healthcare US Corp (US) ', 'Allengers (India) ', 'Dilon Technologies, Inc. (US) ', 'Planmed Oy (Finland) ', 'Delphinus Medical Technologies, Inc. (US) ', 'Micrima Limited (Bristol) ', 'CMR Naviscan (US) ', 'Metaltronic S.p.A (Italy) ', 'CapeRay (South Africa) ', 'Kub Technologies (US) ', 'SonoCine (US) ', 'Imaging Diagnostics Systems, Inc. (US) ', 'Seno Medical (US) ', 'Oncovision (Spain)'

Growing investments in medical imaging R&D has resulted in the development of novel breast imaging technologies and devices. Rising use of these advanced breast imaging solutions to diagnose and treat breast cancer is projected to boost breast imaging market development going forward.

Use of Artificial Intelligence and Machine Learning: Breast imaging providers can explore the integration of machine learning and artificial intelligence to automate their operations and improve the efficiency and accuracy of their solutions. Use of these advanced technologies will also enhance the breast imaging capabilities for breast imaging companies.

North America is projected to account for a dominant share of the global breast imaging market. High awareness regarding breast cancer and surging incidence of the same are projected to primarily augment the demand for breast imaging in this region. Canada and the United States are forecasted to remain as the most opportune markets for breast imaging companies in this region. The presence of key breast imaging providers and high healthcare expenditure are also expected to help the dominance of this region in the future.